Dermatol. praxi. 2012;6(2):81-84

Vulvovaginal candidiasis

MUDr.Marie Koą»álová, Ph.D.
Klinika nemocí koľních a pohlavních FN a LF UK, Hradec Králové

The article presents detailed characteristics of the cause of the disease, clinical symptoms, current diagnostic and therapeutical options.

Differential diagnosis of dermatoses localised in vulvovaginal region is mentioned marginally.

Keywords: candidiasis, virulence factors, sexual transmission, vaginal ecosystem

Published: June 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koą»álová M. Vulvovaginal candidiasis. Dermatol. praxi. 2012;6(2):81-84.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Maąata J. Vulvovaginální infekce. Bulletin Gynestart, 2006; 1: 1-4.
    2. Wagner DK, Sohnle PF. Cutaneous Defense against Dermatophytes and Yeasts. Clinical M icrobiology Review. 1995; 8(3): 317-335. Go to original source... Go to PubMed...
    3. Segal E. Candida, still number one - What do we know and where are we going from there? Mycoses, 2005; 48(1): 3-11. Go to original source... Go to PubMed...
    4. McKay M. Cutaneous manifestation of candidiasis. Am J Obstet Gyencol, 1998; 158(4): 1991-1993.
    5. Gosel, et al. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine. 3rd ed. NY: McGraw-Hill, 1987.
    6. Tömölová Z, Zmrhal J. Mykotické vulvovaginitidy v naąich ambulancích. Prakt Gyn, 2005; 9(2).
    7. Fidel P Jr, Lynch ME, Redondo-Lopez V, et al. Systemic cell-mediated immmune reaktivity in women with recurent vuvlovaginal candidiasis (RVVC). J. Infect. Dis. 1996; 168: 1458-1465. Go to original source... Go to PubMed...
    8. Spinillo A, Capuzzo E, et al. Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol, 1997; 176: 138-141. Go to original source... Go to PubMed...
    9. Kalo-Klein A, Witkin SS. Candida albicans: cellular immune system interactions during different stages of the menstrual cycle. Am J Obstet Gynecol, 1989; 161: 1132-1136. Go to original source... Go to PubMed...
    10. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci, 1988; 544: 547-557. Go to original source... Go to PubMed...
    11. Clemons KV, Spearow JL, et al. Genetic susceptibility of mice to Candida albicans vaginitis correlates with host estrogen sensitivity. Infect Immun, 2004; 72(8): 4878-4880. Go to original source... Go to PubMed...
    12. Loose DS, Feldma D. (1982) Characterisation of a unique corticoserone-binding protein in Candida Albicans. J Biol Chem, 1982; 257: 4925-4930. Go to original source...
    13. Loose DS, Schurman D, Feldman D. A corticosteroid binding protein and endogenous ligand in C. Albicans indicating a possible steroid-receptor system. Nature (London), 1981; 293: 477-479. Go to original source... Go to PubMed...
    14. Kinsman OS, Pitblado K, Coulson CJ. (1988) Mycoses 31: 617-626.
    15. Madani ND, Malloy PJ, et al. Candida albicans estrogen-binding protein gene encodes an oxidoreductase that is inhibited by estradiol, Proc Natl Acad Sci USA, 1994; 91: 922-926. Go to original source... Go to PubMed...
    16. Carlsten H, Holmdahl R, Tarkowski A. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB × NZW) F1 mice. Immunology 1991; 73: 86-190.
    17. Klink M, Rozalaska B, Rundnicka W. Weakness of cellular response to Listeria antigens in pregnant mice. Med Dosw Mikrobiol, 1993; 45: 51-54 (In Polish.). Go to PubMed...
    18. Szekeres-Bartho J. Endrocine regulation of the immune system during pregnancy. Arch Immunol Ther Exp, 1990; 38: 125-140.
    19. Bradshaw CS, Morton AN, et al. Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol, 2005; 106(1): 105-114. Go to original source... Go to PubMed...
    20. Kuklová I, et al. Souvislosti mykotických vulvovaginitid u ľen vyąetřených na venerologické ambulanci I. koľní kliniky, Čes.-slov. Derm, 1997; 4: 134-136.
    21. Čepický P. Kolpitis, Čs. Gynek., 1987; 52: 508-519.
    22. Unzeitig V, Buček R. Poąevní prostředí a jeho mikrobiální profil. Prakt. Lék., 1990; 70(23): 867-8686.
    23. Citterbart K, et al. Gynekologie. Praha: Galén 2001: 110-111.
    24. Unzeitig V. Vulvovaginální ekosystém a poruchy jeho rovnováhy, Lékařské listy 2008; 9: 10-15.
    25. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol, 1986; 152: 924-935. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.